Exploring the efficient natural products for Alzheimer’s disease therapy via Drosophila melanogaster (fruit fly) models

10Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Alzheimer’s disease (AD) is a grievous neurodegenerative disorder and a major form of senile dementia, which is partially caused by abnormal amyloid-beta peptide deposition and Tau protein phosphorylation. But until now, the exact pathogenesis of AD and its treatment strategy still need to investigate. Fortunately, natural products have shown potential as therapeutic agents for treating symptoms of AD due to their neuroprotective activity. To identify the excellent lead compounds for AD control from natural products of herbal medicines, as well as, detect their modes of action, suitable animal models are required. Drosophila melanogaster (fruit fly) is an important model for studying genetic and cellular biological pathways in complex biological processes. Various Drosophila AD models were broadly used for AD research, especially for the discovery of neuroprotective natural products. This review focused on the research progress of natural products in AD disease based on the fruit fly AD model, which provides a reference for using the invertebrate model in developing novel anti-AD drugs.

Cite

CITATION STYLE

APA

Wu, M., Li, Y., Miao, Y., Qiao, H., & Wang, Y. (2023). Exploring the efficient natural products for Alzheimer’s disease therapy via Drosophila melanogaster (fruit fly) models. Journal of Drug Targeting. Taylor and Francis Ltd. https://doi.org/10.1080/1061186X.2023.2245582

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free